mRNA mediates passive vaccination against infectious agents, toxins, and tumors-Reference-Cited by-同舟云学术

mRNA mediates passive vaccination against infectious agents, toxins, and tumors

Published:2017-08-09 Issue:10 Volume:9 Page:1434-1447
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Thran Moritz¹,Mukherjee Jean²,Pönisch Marion¹,Fiedler Katja¹,Thess Andreas¹,Mui Barbara L³,Hope Michael J³,Tam Ying K³,Horscroft Nigel¹,Heidenreich Regina¹,Fotin‐Mleczek Mariola¹,Shoemaker Charles B²,Schlake Thomas¹^ORCID

Affiliation:

1. CureVac AG Tübingen Germany

2. Department of Infectious Disease and Global Health Tufts Cummings School of Veterinary Medicine North Grafton MA USA

3. Acuitas Therapeutics Vancouver BC Canada

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201707678

Reference54 articles.

1. Contributions of humoral and cellular immunity to vaccine-induced protection in humans

2. Antibody-based protection against HIV infection by vectored immunoprophylaxis

3. Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats

4. Monoclonal antibodies for prophylactic and therapeutic use against viral infections

5. Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A decavalent composite mRNA vaccine against both influenza and COVID-19;mBio;2024-09-11

2. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E;Frontiers in Immunology;2024-09-09

3. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends;Biomarker Research;2024-08-31

4. In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection;Molecular Therapy;2024-08

5. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology;Precision Clinical Medicine;2024-07-24